GOLDMAN SACHS GROUP INC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 61 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$1,166,743
-3.3%
111,757
-5.2%
0.00%
Q4 2022$1,206,794
+2.2%
117,8510.0%0.00%
Q3 2022$1,181,000
-85.7%
117,851
-85.7%
0.00%
-100.0%
Q2 2022$8,234,000
+1.0%
825,0940.0%0.00%0.0%
Q1 2022$8,152,000825,0940.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders